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This paper dealt with a novel anti-hypertensive collagen peptide from Chinese soft-shelled turtle 
(Pelodiscus sinensis), which was an efficient inhibitor of angiotensin converting enzyme (ACE, EC 
3.4.15.1). ACE plays an important physiological role in the regulation of blood pressure by virtue of the 
rennin angiotensin system. In traditional Chinese medicine, Chinese soft-shelled turtle possesses many 
health-function properties. This study investigated the effects of Chinese soft-shelled turtle hydrolysate 
(CTH) on ACE inhibition. The CTH showed limited inhibition effect on ACE with an IC50 value at 280 ± 8 
µg/ml, while its graded fraction of molecular weight less than 5000 Da (CTH5K) obtained through 
membrane ultra filtration exhibited better inhibitory activity (IC50 = 190 ± 5 µg/ml). The antioxidant 
activity of CTH was also determined by radical scavenging ability. The CTH5K showed higher 
antioxidant activity. These results indicate that CTH5K possesses potent antihypertensive and 
antioxidant activity, and provides a bioactive peptide material with potential applications as ingredients 
in functional foods. 
 






Hypertension is well known as one of the major risk 
factors of cardiovascular diseases (CVD). The renin–
angiotensin system plays a key role in maintaining blood 
pressure homeostasis as well as fluid and salt balance in 
mammals (Turner and Hooper, 2002). Angiotensin 
converting enzyme (ACE) plays an important role in 
regulating blood pressure in the renin–angiotensin 
system because it catalyses the conversion of 
angiotensin I to angiotensin II (Hernández-Ledesma et al 
2003). High levels of ACE can lead to increased vaso-
constriction and high blood pressure with its 
accompanying pathological symptoms. Due to the 
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may have further effects on different regulatory systems 
involved in immuno-defense and nervous system 
activities (Erdmann et al., 2008). Therefore, inhibition of 
ACE is considered to be an impor-tant therapeutic 
approach for controlling hypertension.  
Bioactive peptides are short sequences fragments that 
have a positive impact on body functions. The bioactive 
peptides can be absorbed in the intestine and enter the 
blood stream directly, which ensures their bioavailability 
in vivo and physiological effect at the target site 
(Erdmann et al., 2008). Bioactive peptides can range 
from 2 to 20 amino acid residues and their activity is 
based on their amino acid composition and sequence 
(Rutherfurd-Markwick and Moughan, 2005; Korhonen, 
2009). Protein hydrolysates are diverse in their functional 
and bioactive properties. 
One approach to improving and upgrading the function-
nal and nutritional properties of proteins is enzymatic 
hydrolysis. Bioactive peptides with ACE inhi-bitory 
abilities are generally derived from egg white hydrolysate 




(Manso et al., 2008), whey proteins (Vermeirssen et al., 
2003), soy proteins (Wu and Ding, 2002), Amaranth seed 
protein (Fritz et al., 2011), by-products proteins such as 
hydrolysates of sardinelle (Sardinella aurita) (Bougatef et 
al., 2010) and so on. Most food protein-derived peptides 
with ACE inhibitory abilities have relatively low molecular 
weight. However, ACE-inhibiting peptides with six, seven 
or 11 amino acids have also been reported (Haque and 
Chand, 2008; Otte et al., 2007). Since the discovery of 
ACE inhibitors in snake venom of Bothrops jararaca 
(Ferreira, 1965), many studies have attempted to 
synthesize ACE inhibitors such as captopril, enalapril 
which are currently used as clinical antihypertensive 
drugs. However, synthetic ACE inhibitors have certain 
side effects such as cough, taste disturbances and skin 
rashes (Li et al., 2004). Therefore, it is necessary to 
search for safe, innovative, and economical ACE 
inhibitors as alternatives to synthetic drugs to prevent and 
treat hypertension.  
In recent years, ACE-inhibiting peptides from food 
sources are promising natural bio-functional alternatives 
to the synthetic drugs. Many ACE-inhibiting peptides 
have been discovered in enzymatic hydrolysates of 
different food-source proteins, and they were to be 
applied in the prevention of hypertension and in the initial 
treatment of mildly hypertensive individuals (Vermeirssen 
et al., 2003; Vercruysse et al., 2005; Guang and Phillips, 
2009). Therefore, searching for natural ACE inhibitors as 
alternatives to synthetic ones is of greater interest for 
safe and economical use as pharmaceuticals. Moreover, 
it is possible to obtain serial enzymatic digestions in a 
system by using a multi-step recycling membrane reactor 
combined with ultrafiltration membrane system to 
separate marine-derived bioactive peptides (Kim et al., 
2001). 
Recently, some protein hydrolysates have been 
reported to exhibit antioxidant activity (Turkoglu et al., 
2007; Bougatef et al., 2010; Zhang et al., 2011). 
Thiansilakul et al. (2007) found that round scad muscle 
hydrolysates produced with flavourzyme exhibited a 
higher 1,1-diphenyl-2-picrylhydrazyl radical 2,2-diphenyl-
1-(2,4,6-trinitrophenyl) hydrazyl (DPPH) radical scaveng-
ing activity and reducing power. Pownall et al. (2011) 
found yellow pea seed protein-derived peptides through 
enzymatic hydrolysis and isolated by ultra filtration with < 
3 kDa sizes have the ability of scavenging O2• and H2O2. 
The antihypertensive effects of collagen hydrolysates 
prepared from various sources and the isolation of 
several ACE-inhibitory peptides from those collagen 
hydrolysates have been reported in previous works (Kim 
et al., 2001; Saiga et al., 2008; Ichimura et al., 2009; Lee 
et al., 2011). In recent years, there are other findings 
showing that ‘low molecular weight collagen hydrolysate’ 
exerts a beneficial effect on osteoporosis by increasing 
the organic substance content of bone in rats (Watanabe-
Kamiyama et al., 2010). Chinese soft-shelled turtle 





has multiple functions in Chinese traditional medicine. 
Feng et al. (1996) demonstrated that long-term oral 
administration of Chinese soft-shelled powder reduces 
the development of hypertension in SHR rats and oral 
administration of Chinese soft-shelled turtle powder 
attenuates fatigue and accelerates recovery from stress 
in mice.  
So, we obtain ACE-inhibiting peptide fractions by ultra 
filtration with neutral protease from Chinese soft-shelled 
turtle hydrolysates (CTH) which is rich in collagen. 
Bioactive peptides as ACE inhibitor also possess anti-
oxidative property and shows cardio-vascular protection 
effects (Beermann et al., 2009). 
ACE inhibitor plays an important role in regulating 
blood pressure while oxidative stress is implicated in the 
pathogenesis of hypertension and stroke (Münzel and 
Keaney, 2001; Fiordaliso et al., 2006). Therefore, anti-




MATERIALS AND METHODS 
 
Chinese soft-shelled turtle was provided by Zhejiang Zhongde 
Agriculture Group Co. Ltd. Neutral protease AS1398 (EC 3.4.24.28) 
was produced by Genencor of Wuxi, China as well as DPPH, 2,2’-
azinobis (3-ethylbenzothiazoline-6- sulfonic acid) (ABTS). ACE (EC 
3.4.15.1) from rabbit lung was purchased from Sigma-Aldrich. 
Hippuryl-L-histidyl-L-leucine (HHL) and captopril were also 
purchased from Sigma-Aldrich. Distilled deionized water was used 
for the preparation of all solutions. All other chemicals were of 
analytical reagent grade. 
 
 
Ultra filtration methods for CTH treatment 
 
Chinese soft-shelled turtle were collected from Zhejiang Zhongde 
agriculture group Co. Ltd in October, 2009 (Hangzhou, Zhejiang 
province). The Chinese soft-shelled turtle scales were washed twice 
in 1.5 mol/L NaCl solution to remove unnecessary proteins on the 
surface. The demineralised scales were washed twice with distilled 
water and then dried. The Chinese soft-shelled turtles were 
powdered using a crushing mill and a standard sample sieve with 
particle diameter of about 0.42 mm and then the powder was 
dispersed in water with a concentration of 50 g/L before hydrolysis. 
The neutral protease AS1398 was used for hydrolysis of the protein 
at a ratio of 1:25 (w:w) enzyme: protein, respectively, at pH 7.0 and 
50°C. Ultra filtration fractions of CTH were prepared using 
membrane followed by MWCO 10 KDa and MWCO 5 KDa. Each 
fraction was collected, and the active fractions were concentrated 
and lyophilized and stored at 4°C for purification. 
 
 
Amino acid composition analysis 
 
CTH were dissolved in 6 mol/L HCl solution at 110°C for 24 h and 




Molecular weight distribution determination 
 
In order to determine the molecular weight distribution of CTH, we 
selected several standard peptides with  different  molecular  weight  



















(MW) at 189, 451, 1450, 6500 and 12400 Da individually. We made 
a figure with LogMW plotted against retention time,  by  high-
performance liquid chromatography. Peptide molecular weight 
standard curve was as followed (Figure 1). The sample was diluted 
with 0.45 µm filter membrane. Chromatographic conditions: waters 
2695 high performance liquid chromatography, waters 2996 diode 
array detector, TSK-GEL G2500PW × L (7.8 × 300 mm, Tosoh 
Corp., Tokyo Japan), Empower Pro data processing software. 
Acetonitrile: water: trifluoroacetic acid (45:55:0.1, v/v/v) as the 
mobile phase, flow rate: 0.5 ml/min, column temperature 30°C and 
the injection volume: 10 µL. 
 
 
Assay of ACE inhibitory activity in vitro 
 
The antihypertensive activity of a peptide is determined based on its 
ACE inhibition rate or IC50 value. A higher ACE inhibition rate or 
lower IC50 value indicates stronger antihypertensive activity. ACE 
inhibition rate is determined based on the reduced percentage of 
peak area of hippuric acid using an adapted high performance 
liquid chromatography (HPLC) method. This method used was 
based on the assay developed by Wu et al. (2002) with some 
modifications. The substrate HHL was dissolved (5 mmol/L) in 0.1 
mol/L sodium-borate buffer (pH 8.3) containing 0.3 mol/L NaCl. The 
assay was performed by mixing 50 µL of substrate solution with 20 
µL of inhibitor solution (or borate buffer for control). After 10 min of 
incubation at 37°C, 20 µL of ACE solution (100 mU/ml) were added 
and the sample was further incubated at 37°C for 30 min. The 
reaction was stopped by the addition of 85 µL of 1 mol/L HCl and 
the solution was filtered through 0.45 µm nylon syringe filter before 
reversed-phase HPLC analysis. The HPLC analysis was performed 
on C18 column (150 × 3.0 mm i.d.), particle size 5 µM with a Varian 
chromatographic system and analytes were detected at the 
wavelength of 228 nm using Captopril as the reference drug. The 
blank group was also prepared using the previously mentioned 
procedure but the diluent was replaced by 0.1 mol/L sodium-borate 
buffer (pH 8.3). 
The mobile phases consisted of solvent A composing of acetic 
acid/distilled water (0.5:99.5, v/v) and solvent B contained 
acetonitrile. HPLC analysis was performed using 5 µL sample and 
20% B in A at a flow rate of 1 ml/min, diode array detector (DAD) 
wavelength of 228 nm, detection temperature of 40°C and runtime 
of 40 min. The ACE inhibition rate (%) was calculated as follows: 
 
R= (A - B) / A*100%. 
 
Here, R is the ACE inhibition rate of peptide (%), A is the peak area 
of hippuric acid in the blank and B is the peak area of  hippuric  acid 
in the diluent. IC50 value is defined as the concentration required to 
decrease the ACE activity by 50%. The determinations were plotted 
for each inhibitor concentration in triplicate. 
 
 
Antioxidant activity of CTH assessment 
 




The antioxidant activities of the CTH were determined by measuring 
the capacity of bleaching a purple colored ethanol solution of 
DPPH
˙
 as described by Turkoglu et al. (2007) with some 
modifications. Various concentrations samples (2 ml) in ethanol 
were added to 2 ml of 0.2 mmol/L DPPH in ethanol. After 30 min 
incubation at room temperature, the absorbance was measured 
against a blank control at 517 nm. Inhibition rate (I%) on DPPH
˙
 
radical was calculated in the following formulation: 
 
I% = (Ablank - Asample / Ablank) × 100% 
 
Here, Ablank is the absorbance of the control reaction (containing all 
reagents except the tested sample) and Asample is the absorbance of 
the tested sample. 
The sample concentration inhibition was calculated from the 
graph of inhibition percentage against sample concentration 
providing Trolox equivalent antioxidant capacity (TEAC), while 
Trolox was calculated as the reference. All determinations were 
performed at least in triplicate. 
 
 






scavenging assay was carried out following a modified 





solution was produced by reacting ABTS
˙+ 
stock solution with 2.45 
mmol/L potassium persulfate in the dark for 12 to 16 h and 
adjusting the absorbance to 0.70 ± 0.02 at 734 nm. For the 
photometric assay, 3 ml of the ABTS
˙+ 
solution and 100 µl samples 
solution were mixed and measured immediately after 6 min at 734 
nm (absorbance did not change significantly up to 10 min). 
Inhibition rate (I%) on ABTS
˙+ 
radical and the sample concentration 
providing TEAC, while Trolox IC50 as the reference which was 
calculated as described in the DPPH
˙
 assay. All determinations 
were performed at least in triplicate. 




Table 1. CTH and CTH5K Amino acid composition analysis. 
 
Amino acid composition CTH (mg/g) CTH5K (mg/g) 
Aspartic acid 39.49 62.967 
Threonine 18.613 28.272 
Serine 20.632 35.762 
Glutamine 62.273 109.235 
Glycine 31.895 132.176 
Alanine 26.384 67.436 
Cysteine 4.942 5.614 
Valine 21.496 26.701 
Methionine 8.590 13.320 
Isoleucine 18.458 22.662 
Leucine 32.930 42.901 
Tyrosine 13.245 14.199 
Phenylalanine 19.383 24.014 
Lysine 37.678 51.031 
Histidine 10.281 16.675 
Arginine 27.442 61.471 
Proline 21.312 76.374 
 
From the amino acid content, there is pure difference between CTH and CTH5K, especially 
hydrophobic amino acids such as Pro from 21.312 mg/g of CTH to 76.374 mg/g of CTH5K, Ala 
from 26.384 mg/g of CTH to 67.436 mg/g of CTH5K, Phe from 19.383 mg/g of CTH to 24.014 
mg/g of CTH5K, Leu from 32.930 mg/g of CTH to 42.901 mg/g of CTH5K, Met from 8.590 mg/g of 
CTH to 13.320 mg/g of CTH5K, Val from 21.496 mg/g of CTH to 26.701 mg/g of CTH5K and Iso 
from 18.458 mg/g of CTH to 22.662 mg/g of CTH5K, which may contribute to ACE inhibitory 




RESULTS AND DISCUSSION 
 
The amino acid composition of CTH 
 
The amino acid composition is shown in Table 1. ACE-
inhibiting peptide contained amino acids such as Pro from 
21.312 mg/g of CTH to 76.374 mg/g of CTH5K, Ala from 
26.384 mg/g of CTH to 67.436 mg/g of CTH5K, Phe from 
19.383 mg/g of CTH to 24.014 mg/g of CTH5K, Leu from 
32.930 mg/g of CTH to 42.901 mg/g of CTH5K, Met from 
8.590 mg/g of CTH to 13.320 mg/g of CTH5K, Val from 
21.496 mg/g of CTH to 26.701 mg/g of CTH5K, Iso from 
18.458 mg/g of CTH to 22.662 mg/g of CTH5K, which 
may contribute to ACE inhibitory activity and antioxidant 
activity. Collagen is one of the unique proteins and they 
are rich in non-polar amino acids such as Gly, Ala, Val 
and Pro. The tripeptides with Trp, Tyr, Phe, Pro and a 
hydrophobic amino acid at the C-terminal were effective 
for ACE inhibitory activity due to interaction with three 
residues at the active site of ACE (Pihlanto-Leppälä et al., 
2000). Biological activities of protein hydrolysates are 
related to amino acid composition and sequence, size 
and configuration of peptides. For example, the presence 
of certain amino acids such as His, Trp, Tyr, Phe, Met, 
Leu, Gly or Pro has been reported to enhance the 
scavenging activities of peptides (Park et al., 2001; 
Mendis et al., 2005; Li et al., 2007). 
Although the structure–activity relationship of food 
derived ACE-inhibiting peptides has not yet been fully 
established, ACE preferred inhibitors containing non-polar 
amino acids has been established. 
 
 
Molecular weight distribution 
 
Generally, enzyme hydrolysates of protein are purified 
based on their molecular weight varied from ultra filtration 
to size exclusion chromatography or both (López-Fandiüo 
et al., 2006; Quirós et al., 2007). Due to lower capacity 
and film blocking problem, process for purification is 
limited. Though hydrophobic amino acid content greatly 
affects ACE inhibition of these peptides, purification 
depends only on their molecular weight. Thus, these pre-
purification methods limit the output of ACE-inhibiting 
peptides especially the method according to molecular 
size separation such as ultra filtration. After the 
separation membrane, we can see polypeptide molecular 
weight distribution: 5 to 2 KDa content is 24.94% in 
CTH5K and 2 to 1 KDa content is 28.46%, while below 1 
KDa is 45% (Figure 2 and Table 2). According to previous 
report, molecular weight below 1 KDa showed potential 
power to be ACE inhibitor and antioxidant. So we 




































Table 2. The CTH5K molecular weight distribution. 
 
Molecular weight (KDa) Retention time (min) Peak area Area (%) 
>5 11.767 137162 1.61 
5 - 2 13.100 2126610 24.94 
2 - 1 13.220 2426501 28.46 
1 - 0.5 14.183 1663331 19.51 
<0.5 15.333 2173340 25.49 
 
After the separation membrane, the polypeptide molecular weight distribution is clearly seen: 5 to 2 




Table 3. ACE inhibition and antioxidant activity of CTH and CTH5K. 
 
Antioxidant ACE inhibition IC50 value IC50 of Scavenging DPPH
˙
(TEAC) IC50 of Scavenging ABTS
˙
(TEAC) 
CTH 280 ± 8 µg/ml 18.79 ± 1.3 mg/g 12.62 ± 0.8 mg/g 
CTH 5K 190 ± 5 µg/ml 27.66 ± 1.7 mg/g 16.95 ± 0.7 mg/g 
 
The IC50 value of ACE inhibition obtained from CTH was 280 ± 8 µg/ml, while the mean value of CTH5K was 190 ± 5 µg/ml. The scavenging 
ability of CTH and CTH5K is lower than that of ascorbic acid; based on TEAC, the hierarchy of ABTS
˙
 radical scavenging activity was in 




ACE inhibition IC50 value of CTH and CTH5K 
 
The ACE inhibition IC50 value obtained from CTH was 
280 ± 8 µg/ml, while the mean value of CTH5K was 190 ± 
5 µg/ml (Table 3). Many studies have reported that ACE 
inhibition of hydrolysates depended on the material 
species and the purity level of the hydrolysate such as 
Alaska pollack frame protein hydrolysate between 1 to 3 
kDa using an ultrafiltration membrane bioreactor system 
with higher ACE inhibition IC50 value of 110 µg/ml, 
while further purification using consecutive chromate-
graphic methods on SP-Sephadex C-25 column and 
HPLC on an octadecylsilane column was 14.7  µg/ml (Je 
et al., 2004). The hydrolysate generated by the crude 
enzyme from Cuttlefish (Sepia officinalis) muscle proteins 
with high inhibition activity 87.11 ± 0.92% at 200 µg/ml, 
while fraction P6 fractionated by size exclusion chroma-
tography on a Sephadex G-25 with higher ACE inhibition. 
This fraction fractionated by reversed-phase (RP)-HPLC, 
and identified of Ala-His-Ser-Tyr, Gly-Asp-Ala-Pro, Ala-
Gly-Ser-Pro and Asp-Phe-Gly displayed the highest ACE 
inhibition with an IC50 of 11.6 µmol/L (Balti et al., 2010). 
Pacific hake hydrolysates prepared with ultrafiltration 
(10 kDa molecular mass cutoff) showed an IC50 value of 
44 ± 7 µg of peptides, 2.5 times than the commercial 
product  PeptACE  peptides  (IC50 = 114 ± 8 µg/ml), which 




may be a commercially competitive source of ACE-
inhibitory peptides (Cinq-Mars and Li-Chan, 2007). 
CTH5K showed higher inhibition activity than CTH 
through ultra filtration and had relatively good stability 









DPPH assay has been widely used to provide basic 
information on the antioxidant ability of extracts from 
plant, food material or single compounds because this 
method has shown to be rapid and simply available. 
DPPH is a stable free radical with a characteristic 
absorption which decreases significantly on exposure to 
proton radical scavengers (Singh et al., 2009). CTH5K 
showed better scavenging activities to reduce the stable 
radical DPPH
˙
 to yellow-colored diphenyl picrylhydrazine 
in a concentration dependent manner than CTH. 
However, based upon the estimated TEAC, all fractions 
were relatively lower than ascorbic acid, a known 
antioxidant used as positive control. However, CTH and 










˙+ is another synthetic radical and more versatile 
than DPPH
˙
 because the ABTS
˙+ model can assess the 
scavenging activity for both the polar and non-polar 
samples. What is more, the spectral interference is 
lessened in the absorption maximum and often evaluated 
by natural products. Therefore, it was considered 
necessary to further assess the CSSTH against the 
synthetic ABTS
˙+ free radical. The CTH and CTH5K were 
also able to scavenge ABTS
˙+ radicals. The scavenging 
ability of CTH and CTH5K is lower than that of ascorbic 
acid, based on TEAC, the hierarchy of ABTS
˙+ radical 
scavenging activity was in agreement with that of DPPH 





CTH5K which is rich in collagen shows the property as 
ACE inhibitor and anti-oxidative peptides in vitro. The 
fractions exhibiting stronger activity will be further 
fractionated and screened for bioactivity using RP-HPLC. 
Peptides with stronger activity will be further sequenced 
and characterized by HPLC– mass spectrometry (MS). 
After the separation membrane, we can see below the 
molecular weight polypeptide 1 KDa in 45% of CTH5K. 
The membrane technology is suitable for industrial 





of CTH5K showed better repeatability which would be an 
attractive choice for commercial application as safe and 
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